LUCD
Lucid Diagnostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$204.11M
P/E Ratio
—
EPS
$-0.34
Beta
1.10
52W High
$1.70
52W Low
$0.90
50-Day MA
$1.15
200-Day MA
$1.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lucid Diagnostics Inc
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $5.13M |
| Gross Profit (TTM) | $-1.61M |
| EBITDA | $-48.39M |
| Operating Margin | -964.00% |
| Return on Equity | -711.00% |
| Return on Assets | -92.10% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $-0.04 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 39.76 |
| EV/Revenue | 41.15 |
| EV/EBITDA | -0.68 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 51.70% |
| Shares Outstanding | $190.76M |
| Float | $140.58M |
| % Insiders | 26.53% |
| % Institutions | 19.37% |
Historical Volatility
HV 10-Day
54.26%
HV 20-Day
43.47%
HV 30-Day
84.02%
HV 60-Day
64.24%
HV Rank
82.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.90 target)
2
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026